Membranous nephropathy

515,795views

test

00:00 / 00:00

Membranous nephropathy

my

my

Muscular system anatomy and physiology
Anatomy of the vertebral canal
Slow twitch and fast twitch muscle fibers
Brachial plexus
Sliding filament model of muscle contraction
Skeletal muscle histology
Lower back pain: Clinical
Back pain: Pathology review
Muscles of the back
Mesoderm
Myasthenia gravis
Cholinergic receptors
Adrenergic receptors
Alopecia: Clinical
Atopic dermatitis
Acne vulgaris
Local anesthetics
Muscles of the gluteal region and posterior thigh
Anatomy of the tibiofibular joints
Spinal muscular atrophy
Eczematous rashes: Clinical
Osteomalacia and rickets
Osteoporosis
Anatomy of the popliteal fossa
Paget disease of bone
Development of the axial skeleton
Anatomy of the anterior and medial thigh
Bone tumors
Bone tumors: Pathology review
Bone disorders: Pathology review
Oncogenes and tumor suppressor genes
Pediatric bone tumors: Clinical
Pediatric infectious rashes: Clinical
Anatomy clinical correlates: Bones, joints and muscles of the back
Bones of the vertebral column
Sciatica
Charcot-Marie-Tooth disease
Meniscus tear
Somatosensory receptors
Neuromuscular junction and motor unit
Osteoarthritis
Gout
Clostridium tetani (Tetanus)
Muscle spindles and golgi tendon organs
Vessels and nerves of the gluteal region and posterior thigh
Pediatric orthopedic conditions: Clinical
Achondroplasia
Diagnostic skills
Clinical Skills: Pulses assessment
Clinical Skills: Pulse oximetry
Clinical Skills: Respiratory rate assessment
Clinical Skills: Body Temperature Assessment
Clinical Skills: Obtaining blood pressure assessment
Osteoporosis medications
Osteogenesis imperfecta
Muscles of the forearm
Anatomy of the brachial plexus
Muscle contraction
Hashimoto thyroiditis
Hypothyroidism: Pathology review
Hyperthyroidism: Clinical
Rheumatoid arthritis and osteoarthritis: Pathology review
Joint pain: Clinical
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Gene regulation
Alpha-thalassemia
Beta-thalassemia
Bone remodeling and repair
Glycogen metabolism
Glycogen storage disease type I
Familial hypercholesterolemia
Hypercholesterolemia: Clinical
Sickle cell disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Intrinsic hemolytic normocytic anemia: Pathology review
Von Willebrand disease
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Factor V Leiden
Platelet disorders: Pathology review
Role of Vitamin K in coagulation
Transcription of DNA
DNA replication
Protein C deficiency
Spina bifida
Chiari malformation
Syringomyelia
Anatomy clinical correlates: Wrist and hand
Joints of the wrist and hand
Skin cancer
Epstein-Barr virus (Infectious mononucleosis)
Human papillomavirus
Human herpesvirus 8 (Kaposi sarcoma)
Anti-tumor antibiotics
Turner syndrome
Hyponatremia
Body fluid compartments
Hydration
Movement of water between body compartments
Dyslipidemias: Pathology review
Introduction to pharmacology
Medication overdoses and toxicities: Pathology review
Vibrio cholerae (Cholera)
Cell signaling pathways
Resting membrane potential
Thyroid hormones
Muscular dystrophy
Integumentary system: Skin lesions
Development of the muscular system
Bones of the upper limb
Bones of the lower limb
Anthelmintic medications
Streptococcus pyogenes (Group A Strep)
Mycobacterium tuberculosis (Tuberculosis)
Fatty acid oxidation
Nephrotic syndromes: Pathology review
Glomerular filtration
Nephritic and nephrotic syndromes: Clinical
Nephritic syndromes: Pathology review
Membranous nephropathy
Membranoproliferative glomerulonephritis
Cardiomyopathies: Clinical
ECG QRS transition

Assessments

Flashcards

0 / 10 complete

USMLE® Step 1 questions

0 / 2 complete

High Yield Notes

9 pages

Flashcards

Membranous nephropathy

0 of 10 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A 52-year-old female comes to the primary care physician due to worsening weight gain. She has gained approximately 20 lbs over the past six weeks. In addition, the patient has been experiencing lower extremity edema and has noticed her urine appears more cloudy than usual. Past medical history is notable for hypertension and hyperlipidemia. Temperature is 37.3°C (99.1°F), pulse is 76/min, respirations are 18/min, blood pressure is 137/84 mmHg, and O2 saturation is 97% on room air. Physical exam is notable for bilateral pitting edema of the lower extremities. A urinalysis is notable for 4+ protein and oval fat bodies but no hematuria. A renal biopsy is performed, and the following is visualized on light microscopy:  


Reproduced from: Wikipedia  
Which of the following is most suggestive of this patient’s underlying diagnosis?  

External References

First Aid

2024

2023

2022

2021

Membranous nephropathy p. 612, 613, 729

membranous nephropathy, primary

autoantibody p. 113

Transcript

Watch video only

Content Reviewers

Membranous glomerulonephritis, also known as membranous nephropathy, is where the glomerular basement membrane, or GBM, which lines the glomeruli in the kidney, becomes inflamed and damaged, which results in increased permeability and proteins being able to filter through into the urine, causing nephrotic syndrome.

But what exactly is nephrotic syndrome? Well usually the glomerulus only lets small molecules, like sodium and water, move from the blood into the kidney nephron, where it eventually makes its way into the urine. But with nephrotic syndromes, the glomeruli are damaged and they become more permeable, so they start letting plasma proteins come across from the blood to the nephron and then into the urine, which causes proteinuria, typically greater than 3.5 grams per day.

An important protein in the blood is albumin, and so when it starts leaving the blood, people get hypoalbuminemia—low albumin in the blood.

With less protein in the blood the oncotic pressure falls, which lowers the overall osmotic pressure, which drives water out of the blood vessels and into the tissues, called edema.

Finally, it’s thought that as a result of either losing albumin or losing some protein or proteins that inhibit the synthesis of lipids, or fat, you get increased levels of lipid in the blood, called hyperlipidemia.

Just like the proteins, these lipids can also get into the urine, causing hyperlipiduria.

And those are the hallmarks of nephrotic syndrome—proteinuria, hypoalbuminemia, edema, hyperlipidemia, and lipiduria.

Alright, so with membranous glomerulonephritis, the basement membrane becomes damaged which causes nephrotic syndrome. How does this happen, though? Well, ultimately this damage is caused by immune complexes—complexes composed of an antigen with an antibody bound to it.

One way these complexes can form is as a result of autoantibodies directly targeting the glomerular basement membrane.

Two major antigen targets that’ve been identified are the M-type phospholipase A2 receptor and neutral endopeptidase, which are both expressed on the podocyte surface—the cells that line the basement membrane, and we know this because a large proportion of cases, people with membranous glomerulonephritis have antibodies against these autoantigens in their bloodstream.

Immune complexes, though, might also form outside of the kidney, and then get carried through the bloodstream to the glomerulus and deposit in the basement membrane.

One potential circulating antigen that’s been identified is cationic bovine serum albumin, which is present in cow’s milk and beef protein, and can escape the intestinal barrier, cause immune complex formation, and deposit in the GBM.

Whether they bind directly to the GBM, or come from somewhere else, these immune complexes are called subepithelial deposits because they’re sandwiched right between the epithelial cells or podocytes, and the GBM.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Membranous nephropathy in children: clinical presentation and therapeutic approach" Pediatric Nephrology (2009)
  6. "Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy" New England Journal of Medicine (2014)
  7. "Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome" Cochrane Database of Systematic Reviews (2014)
  8. "Membranous Glomerulopathy: Emphasis on Secondary Forms and Disease Variants" Advances in Anatomic Pathology (2001)